Clinical trial
Study of Subcutaneous Rehydration With Recombinant Human Hyaluronidase for…
NCT00477152 · Baxter Healthcare Corporation, Industry · Completed
Key facts
| NCT number | NCT00477152 |
|---|---|
| Title | Study of Subcutaneous Rehydration With Recombinant Human Hyaluronidase for Infants and Children |
| Official title | INcreased Flow Utilizing Subcutaneously-Enabled Pediatric Rehydration (INFUSE-Pediatric Rehydration Study): Phase IV Study of Subcutaneous Rehydration With Recombinant Human Hyaluronidase (HYLENEX) for Infants and Children |
| Acronym | INFUSE-PR |
| Lead sponsor | Baxter Healthcare Corporation, Industry |
| Collaborators | Halozyme Therapeutics Industry PPD Development, LP |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Dehydration |
| Intervention type | Drug |
| Interventions | hyaluronidase (human recombinant)/rehydration fluid |
| Enrollment | 52 |
| Start date | Aug 1, 2007 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | May 22, 2007 |
| Last update posted | Dec 1, 2011 |
At a glance
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: